BIIB.NASDAQBiogen INC

Form 4: Biogen Executive Receives Stock Grant

Sentiment:

Insider Transaction (Form 4)


Sean Godbout, Chief Accounting Officer of Biogen Inc., reported multiple transactions in common stock on October 1, 2026.

Summary

  • Option exercise/conversion: acquired 27 Common Stock on October 2, 2026; holds 1,467 after (Direct).
  • Tax/exercise-price withholding: disposed of 8 Common Stock at $219.88 ($1,759) on October 2, 2026; holds 1,459 after (Direct).
  • Grant/award: acquired 985 Restricted Stock Unit on October 1, 2026; holds 985 after (Direct).
  • Option exercise/conversion: disposed of 27 Restricted Stock Unit on October 2, 2026 (Direct).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

Sean Godbout — Officer (Chief Accounting Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-10-02Option exercise/conversionCommon Stock27——1,466.985
2026-10-02Tax/exercise-price withholdingCommon Stock8$220$1.8K1,458.985
2026-10-01Grant/awardRestricted Stock Unit985——985
2026-10-02Option exercise/conversionRestricted Stock Unit27——0

Key Dates

DateDescription
2026-10-02Option exercise/conversion (27 shares)
2026-10-02Tax/exercise-price withholding (8 shares)
2026-10-01Grant/award (985 shares)
2026-10-02Option exercise/conversion (27 shares)

Keywords

insider transaction, Form 4, BIIB, BIOGEN INC., neutral, Sean Godbout

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.